Aimed Bio&#39;s Antibody-Drug Conjugate (ADC) new drug candidate &quot;BI 4060107 (development code name ODS025),&quot; which was licensed out to C. H. Boehringer Sohn AG &amp; Co. KG, received approval for a phase 1 investigational new drug (IND) application in Japan.